Cargando…
The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
BACKGROUND: Aberrant methylation of EphA7 has been reported in the process of carcinogenesis but not in cervical cancer. Therefore, an integration study was performed to explore the association between EphA7 hypermethylation and cervical cancer and validate the potential value of EphA7 hypermethylat...
Autores principales: | Zhang, Wenfan, Cao, Huiling, Yang, Jinhao, Zhao, Jing, Liang, Zheng, Kang, Xiaodong, Wang, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185921/ https://www.ncbi.nlm.nih.gov/pubmed/35681118 http://dx.doi.org/10.1186/s12885-022-09653-7 |
Ejemplares similares
-
SOX14 hypermethylation as a tumour biomarker in cervical cancer
por: Zhao, Jing, et al.
Publicado: (2021) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region
por: Liu, Jie, et al.
Publicado: (2022) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Modulation of EphA7 and pEphA7 Protein Expression: Potential Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Priya, Shivani, et al.
Publicado: (2022)